Death domain containing receptor 5
AssigneeHuman Genome Sciences, Inc.
InventorsJian Ni, Reiner L. Gentz, Guo-Liang Yu, Jeffrey Y. Su, Craig A. Rosen
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel Death Domain Containing Receptor-5 (DR5) proteins which are members of the tumor necrosis factor (TNF) receptor family, and have now been shown to bind TRAIL. In particular, isolated nucleic acid molecules are provided encoding the human DR5 proteins. DR5 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying antagonists and antagonists of DR5 activity.
Claims50
An isolated polynucleotide comprising a nucleic acid which encodes amino acids 1 to 360 of SEQ ID NO:2.
An isolated polynucleotide comprising a nucleic acid which encodes the mature amino acid sequence encoded by the cDNA clone in ATCC Deposit No. 97920.
An isolated polynucleotide which encodes amino acids 1 to 133 of SEQ ID NO:2.
Dependencies are inferred from the claim text.